Sf-RVN Cell Recombinant Trivalent Poliomyelitis Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sf-RVN Cell Recombinant Trivalent Poliomyelitis Vaccine, covering 2024-12-04 to 2024-12-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults [Phase 1]